NTI 2.38% 8.6¢ neurotech international limited

Yes, top line data only. The benefit (as measured by CGI-I) of...

  1. 2,304 Posts.
    lightbulb Created with Sketch. 328
    Yes, top line data only. The benefit (as measured by CGI-I) of NTI164 is the same as FDA approved DAYBUE (-0.3) which is good.

    The secondary endpoint data will be instructive - if the side effects of the NTI drug are better than DAYBUE then that may be a selling point.
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.